shRNA targeting of ferritin heavy chain activates H19/miR-675 axis in K562 cells. 2018

M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
Centro di Ricerca di Biochimica e Biologia Molecolare Avanzata, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi "Magna Græcia", Catanzaro, Italy; Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi "Magna Græcia", Catanzaro, Italy.

OBJECTIVE The heavy subunit of the iron storage protein ferritin (FHC) is essential for the intracellular iron metabolism and, at the same time, it represents a central hub of iron-independent pathways, such as cell proliferation, angiogenesis, p53 regulation, chemokine signalling, stem cell expansion, miRNAs expression. In this work we have explored the ability of FHC to modulate gene expression in K562 cells, through the up-regulation of the lncRNA H19 and its cognate miR-675. METHODS Targeted silencing of FHC was performed by lentiviral-driven shRNA strategy. FHC reconstitution was obtained by full length FHC cDNA transfection with Lipofectamine 2000. ROS amounts were determined with the redox-sensitive probe H2DCFDA. H19, miR-675, miR-107, Twist1, ID3, EPHB6, GNS, ANK1 and SMAD6 mRNA amounts were quantified by Taqman assay and qPCR analysis. RESULTS FHC silencing in K562 cells modulates gene expression through the up-regulation of the lncRNA H19 and its cognate miR-675. Experimental findings demonstrate that the molecular mechanism underlying this phenomenon is represented by an FHC knock-down-triggered increase in reactive oxygen species (ROS) production. CONCLUSIONS In this paper we uncover a so far not described function of the ferritin heavy subunit in the control of lncRNA pathways.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D005293 Ferritins Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types. Basic Isoferritin,Ferritin,Isoferritin,Isoferritin, Basic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015854 Up-Regulation A positive regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Up-Regulation,Upregulation,Up-Regulation (Physiology),Up Regulation
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen
D053263 Gene Regulatory Networks Interacting DNA-encoded regulatory subsystems in the GENOME that coordinate input from activator and repressor TRANSCRIPTION FACTORS during development, cell differentiation, or in response to environmental cues. The networks function to ultimately specify expression of particular sets of GENES for specific conditions, times, or locations. Gene Circuits,Gene Modules,Gene Networks,Transcriptional Networks,Gene Module,Circuit, Gene,Circuits, Gene,Gene Circuit,Gene Network,Gene Regulatory Network,Module, Gene,Modules, Gene,Network, Gene,Network, Gene Regulatory,Network, Transcriptional,Networks, Gene,Networks, Gene Regulatory,Networks, Transcriptional,Regulatory Network, Gene,Regulatory Networks, Gene,Transcriptional Network
D062085 RNA, Long Noncoding A class of untranslated RNA molecules that are typically greater than 200 nucleotides in length and do not code for proteins. Members of this class have been found to play roles in transcriptional regulation, post-transcriptional processing, CHROMATIN REMODELING, and in the epigenetic control of chromatin. LincRNA,RNA, Long Untranslated,LINC RNA,LincRNAs,Long Intergenic Non-Protein Coding RNA,Long Non-Coding RNA,Long Non-Protein-Coding RNA,Long Noncoding RNA,Long ncRNA,Long ncRNAs,RNA, Long Non-Translated,lncRNA,Long Intergenic Non Protein Coding RNA,Long Non Coding RNA,Long Non Protein Coding RNA,Long Non-Translated RNA,Long Untranslated RNA,Non-Coding RNA, Long,Non-Protein-Coding RNA, Long,Non-Translated RNA, Long,Noncoding RNA, Long,RNA, Long Non Translated,RNA, Long Non-Coding,RNA, Long Non-Protein-Coding,Untranslated RNA, Long,ncRNA, Long,ncRNAs, Long
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562
D020868 Gene Silencing Interruption or suppression of the expression of a gene at transcriptional or translational levels. Gene Inactivation,Inactivation, Gene,Silencing, Gene

Related Publications

M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
August 2014, The FEBS journal,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
October 2016, Scientific reports,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
January 2019, Molecular immunology,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
June 2019, Archives of oral biology,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
June 2022, Microbiology spectrum,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
January 2019, Current molecular pharmacology,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
March 2018, Biochemical and biophysical research communications,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
November 2017, Clinical science (London, England : 1979),
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
January 2022, Journal of applied oral science : revista FOB,
M Di Sanzo, and R Chirillo, and I Aversa, and F Biamonte, and G Santamaria, and E D Giovannone, and M C Faniello, and G Cuda, and F Costanzo
June 2022, European review for medical and pharmacological sciences,
Copied contents to your clipboard!